Open AccessGrafalon® vs. Thymoglobulin® as an induction agent in renal transplantation – A retrospective study
Author(s) -
Pranaw Kumar Jha,
Alka Rana,
Ajay Kher,
Shyam Bihari Bansal,
Sidharth Kumar Sethi,
Ashish Nandwani,
Manish Jain,
Dinesh Bansal,
Dinesh Kumar Yadav,
Ashwini Gadde,
Amit Kumar Mahapatra,
Puneet Sodhi,
Vijay Kher
Publication year - 2021
Publication title -
indian journal of nephrology/indian journal of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.317
H-Index - 24
eISSN - 1998-3662
pISSN - 0971-4065
DOI - 10.4103/ijn.ijn_205_20
Subject(s) - thymoglobulin , medicine , kidney transplantation , renal function , transplantation , retrospective cohort study , immunosuppression , single center , urology , surgery , gastroenterology
Antihuman thymocyte immunoglobulin, used as an induction agent in renal transplantation, is of two types - thymoglobulin and grafalon (formerly ATG-Fresenius). In this study, we compared outcomes with these two agents.